- Home
- OPXS vs COEP Comparison
OPXS vs COEP Comparison
Compare OPXS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- COEP
- Stock Information
- Founded
- OPXS 1987
- COEP 2017
- Country
- OPXS United States
- COEP United States
- Employees
- OPXS N/A
- COEP N/A
- Industry
- OPXS Electronic Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPXS Technology
- COEP Health Care
- Exchange
- OPXS Nasdaq
- COEP Nasdaq
- Market Cap
- OPXS 75.8M
- COEP 62.4M
- IPO Year
- OPXS N/A
- COEP N/A
- Fundamental
- Price
- OPXS $12.37
- COEP $12.60
- Analyst Decision
- OPXS
- COEP
- Analyst Count
- OPXS 0
- COEP 0
- Target Price
- OPXS N/A
- COEP N/A
- AVG Volume (30 Days)
- OPXS 46.1K
- COEP 39.1K
- Earning Date
- OPXS 08-12-2025
- COEP 11-12-2025
- Dividend Yield
- OPXS N/A
- COEP N/A
- EPS Growth
- OPXS 23.32
- COEP N/A
- EPS
- OPXS 0.75
- COEP N/A
- Revenue
- OPXS $39,481,000.00
- COEP $263,555.00
- Revenue This Year
- OPXS N/A
- COEP N/A
- Revenue Next Year
- OPXS N/A
- COEP N/A
- P/E Ratio
- OPXS $16.24
- COEP N/A
- Revenue Growth
- OPXS 21.00
- COEP N/A
- 52 Week Low
- OPXS $5.36
- COEP $2.31
- 52 Week High
- OPXS $14.60
- COEP $14.70
- Technical
- Relative Strength Index (RSI)
- OPXS 58.18
- COEP 51.40
- Support Level
- OPXS $11.05
- COEP $12.09
- Resistance Level
- OPXS $12.22
- COEP $13.25
- Average True Range (ATR)
- OPXS 0.59
- COEP 0.73
- MACD
- OPXS 0.15
- COEP -0.12
- Stochastic Oscillator
- OPXS 94.15
- COEP 45.78
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.